Literature DB >> 27711059

A broader spectrum of tuberculosis.

Dirk Schnappinger1, Sabine Ehrt1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27711059     DOI： 10.1038/nm.4186

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Tuberculosis.

Authors:  Alimuddin Zumla; Mario Raviglione; Richard Hafner; C Fordham von Reyn
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

2.  A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1986-07

3.  Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

Authors:  Galina V Mukamolova; Obolbek Turapov; Joanne Malkin; Gerrit Woltmann; Michael R Barer
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

4.  Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.

Authors:  Melissa D Chengalroyen; Germar M Beukes; Bhavna G Gordhan; Elizabeth M Streicher; Gavin Churchyard; Richard Hafner; Robin Warren; Kennedy Otwombe; Neil Martinson; Bavesh D Kana
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

Review 5.  Long term efficacy of DOTS regimens for tuberculosis: systematic review.

Authors:  Helen S Cox; Martha Morrow; Peter W Deutschmann
Journal:  BMJ       Date:  2008-02-04

6.  Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.

Authors:  Philana Ling Lin; Christopher B Ford; M Teresa Coleman; Amy J Myers; Richa Gawande; Thomas Ioerger; James Sacchettini; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Med       Date:  2013-12-15       Impact factor: 53.440

7.  Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure.

Authors:  Stephanus T Malherbe; Shubhada Shenai; Katharina Ronacher; Andre G Loxton; Gregory Dolganov; Magdalena Kriel; Tran Van; Ray Y Chen; James Warwick; Laura E Via; Taeksun Song; Myungsun Lee; Gary Schoolnik; Gerard Tromp; David Alland; Clifton E Barry; Jill Winter; Gerhard Walzl; Lance Lucas; Gian van der Spuy; Kim Stanley; Lani Thiart; Bronwyn Smith; Nelita Du Plessis; Caroline G G Beltran; Elizna Maasdorp; Annare Ellmann; Hongjo Choi; Joonsung Joh; Lori E Dodd; Brian Allwood; Coenie Koegelenberg; Morné Vorster; Stephanie Griffith-Richards
Journal:  Nat Med       Date:  2016-09-05       Impact factor: 53.440

Review 8.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

9.  Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs.

Authors:  Obolbek Turapov; Benjamin D O'Connor; Asel A Sarybaeva; Caroline Williams; Hemu Patel; Abdullaat S Kadyrov; Akpay S Sarybaev; Gerrit Woltmann; Michael R Barer; Galina V Mukamolova
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

10.  Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography.

Authors:  Hanif Esmail; Rachel P Lai; Maia Lesosky; Katalin A Wilkinson; Christine M Graham; Anna K Coussens; Tolu Oni; James M Warwick; Qonita Said-Hartley; Coenraad F Koegelenberg; Gerhard Walzl; JoAnne L Flynn; Douglas B Young; Clifton E Barry Iii; Anne O'Garra; Robert J Wilkinson
Journal:  Nat Med       Date:  2016-09-05       Impact factor: 53.440
View more
  5 in total

Review 1.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

2.  Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.

Authors:  Simon G Kimuda; Irene Andia-Biraro; Moses Egesa; Bernard S Bagaya; John G Raynes; Jonathan Levin; Alison M Elliott; Stephen Cose
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

3.  Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis.

Authors:  Mary A De Groote; David G Sterling; Thomas Hraha; Theresa M Russell; Louis S Green; Kirsten Wall; Stephan Kraemer; Rachel Ostroff; Nebojsa Janjic; Urs A Ochsner
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

4.  Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis.

Authors:  Antonia M I Saktiawati; Ymkje Stienstra; Yanri W Subronto; Ning Rintiswati; Jan-Willem Gerritsen; Henny Oord; Onno W Akkerman; Tjip S van der Werf
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

5.  18F-FDG Positron-Emission Tomography/Computed Tomography Findings of Radiographic Lesions Suggesting Old Healed Pulmonary Tuberculosis and High-risk Signs of Predicting Recurrence: A Retrospective Study.

Authors:  Yu Ji; Chunchun Shao; Yong Cui; Guangrui Shao; Jingsong Zheng
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.